BDBM50265537 (S)-N1-((5R,8S,11R,17R,20S,23R)-11-((1H-imidazol-4-yl)methyl)-5-carbamoyl-24-(1H-indol-3-yl)-8-isobutyl-17-isopropyl-20-methyl-7,10,13,16,19,22-hexaoxo-2-thia-6,9,12,15,18,21-hexaazatetracosan-23-yl)-2-aminopentanediamide::CHEMBL445221

SMILES CSCC[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(N)=O

InChI Key InChIKey=VZGJNCHEUPMLPM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50265537   

TargetIntegrin alpha-V(Human)
Stanford University School of Medicine

Curated by ChEMBL
LigandPNGBDBM50265537((S)-N1-((5R,8S,11R,17R,20S,23R)-11-((1H-imidazol-4...)
Affinity DataIC50: 79.0nMAssay Description:Displacement of [125I][Tyr4]BBN form integrin alphaVbeta3 receptor in human PC3 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed